Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial
Bengt I. Eriksson(Sahlgrenska University Hospital), O.E. Dahl(Thrombosis Research Institute), Nadia Rosencher(Université Paris Cité), Andreas Kurth(Orthopaedic University Hospital Friedrichsheim), C. Niek van Dijk(Amsterdam UMC Location University of Amsterdam), Simon P. Frostick(University of Liverpool), Peter Kälebo(Sahlgrenska University Hospital), Anita Vedel Christiansen(Boehringer Ingelheim (Denmark)), Stefan Hantel(Boehringer Ingelheim (Germany)), Rohan Hettiarachchi(Boehringer Ingelheim (Netherlands)), Janet Schnee(Boehringer Ingelheim (United States)), Harry R. Büller(Amsterdam UMC Location University of Amsterdam)
Cited by 983Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis